Ranganath R, Hui Monalisa, Uppin Shantveer, Jena S, Shantappa Rajshekar
Department of Surgical Oncology, Nizam's Institute of Medical Sciences, Hyderabad, TG India.
Department of Pathology, Nizam's Institute of Medical Sciences, Hyderabad, TG India.
Indian J Surg Oncol. 2023 Jun;14(2):492-496. doi: 10.1007/s13193-022-01532-8. Epub 2022 Apr 18.
To audit the use of breast conservation surgery for breast cancer treatment in a tertiary care centre over a 7-year period, and also to chart the clinical, demographic and pathological characteristics of breast cancer patients treated in the setting of a referral centre in a middle income (MDI) group country. A retrospective analysis of the case records of all patients of invasive breast cancer treated at our institute between January 2014 and December 2020 was done after obtaining approval from the Institute Ethics Committee (IEC). The number of patients seen, age, parity, menopausal status, family history of cancer, laterality, site of tumour in the breast, the symptomatology, clinical stage and presence or absence of metastases was the clinical parameters examined. The pathological stage and grade of the tumour, receptor status, treatment offered according to stage and the patterns of failure with respect to the surgery performed were recorded. Statistical analysis was a direct head to head comparison of the percentage proportions of the different variables. A total of 685 patients of breast cancer were treated between January 2014 and December 2020. A total of 53% of the cohort was more than 45 years old and 56.7% were post menopausal. A total of 58.8% of the patients presented with a cancer in the left breast and in the upper outer quadrant. Nearly 41% of the tumours were more than 4 cm in size. The most common receptor profile in our patient population was ER positive, PR positive and HER 2 negative. A total of 27.7% of the patients were offered neo-adjuvant chemotherapy and 63.06% underwent upfront surgery. A total of 19.7% of all surgeries performed (overall) were breast conservation surgeries (BCS). The use of BCS showed an increasing trend over the 7 years studied rising from 16.79 to 25% (annually). The local failure rate for BCS was 11.8% but the incidence of distant metastases was not significantly different compared to the patients who underwent a mastectomy. Breast conservation is safe and feasible in a referral setting even in a middle income nation with multi-disciplinary treatment planning and needs to be adopted widely to preserve the body image and self esteem of patients with breast cancer.
为审核一家三级医疗中心在7年期间乳腺癌保乳手术的使用情况,并梳理在一个中等收入(中低收入)国家转诊中心接受治疗的乳腺癌患者的临床、人口统计学和病理特征。在获得机构伦理委员会(IEC)批准后,对2014年1月至2020年12月期间在我们研究所接受治疗的所有浸润性乳腺癌患者的病例记录进行了回顾性分析。所检查的临床参数包括就诊患者数量、年龄、胎次、绝经状态、癌症家族史、患侧、乳房肿瘤部位、症状、临床分期以及有无转移。记录肿瘤的病理分期和分级、受体状态、根据分期提供的治疗以及所施行手术的失败模式。统计分析是对不同变量的百分比比例进行直接的一对一比较。2014年1月至2020年12月期间共治疗了685例乳腺癌患者。该队列中共有53%的患者年龄超过45岁,56.7%为绝经后患者。共有58.8%的患者左侧乳房上外象限患癌。近41%的肿瘤大小超过4厘米。我们患者群体中最常见的受体特征是雌激素受体(ER)阳性、孕激素受体(PR)阳性和人表皮生长因子受体2(HER 2)阴性。共有27.7%的患者接受了新辅助化疗,63.06%的患者接受了 upfront 手术。所有手术(总体)中共有19.7%是保乳手术(BCS)。在研究的7年中,保乳手术的使用呈上升趋势,从1 . 679%升至25%(每年)。保乳手术的局部失败率为11.8%,但远处转移的发生率与接受乳房切除术的患者相比无显著差异。即使在一个中等收入国家,在多学科治疗规划的转诊环境中,保乳手术也是安全可行的,需要广泛采用以维护乳腺癌患者的身体形象和自尊。